MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
INAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

IN8bio (INAB) Ownership - Who owns IN8bio?

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
350 5th Avenue
Phone
+1 646 600-6438
Employees
17
Web
https://www.in8bio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
14.05M
P/E Ratio
N/A
Total Cash
21.94M
Projected Growth
N/A
Total Debt
2.35M
Revenue
N/A
Risk (Beta)
0.31
Dividend Yield
N/A
Total Cash/Share
2.29
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
INAB
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for INAB
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
350 5th Avenue
Phone
+1 646 600-6438
Employees
17
Web
https://www.in8bio.com